This topic contains a solution. Click here to go to the answer

Author Question: What is the major contributing factor in the development of postoperative atelectasis? a. ... (Read 59 times)

MirandaLo

  • Hero Member
  • *****
  • Posts: 538
What is the major contributing factor in the development of postoperative atelectasis?
 
  a. Uncontrolled hyperpyrexia
  b. Central nervous system overstimulation
  c. Decreased cardiac output
  d. Repetitive, shallow breathing

Question 2

Which of the following groups of patients is not at risk for developing postoperative atelectasis?
 
  a. Those with chronic obstructive pulmonary disease
  b. Those with a significant history of ciga-rette smoking
  c. Those with impaired mucociliary clearance
  d. Those with pneumonia



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

ghepp

  • Sr. Member
  • ****
  • Posts: 361
Answer to Question 1

ANS: D
Most postoperative patients also have problems coughing effectively because of their reduced ability to take deep breaths.

Answer to Question 2

ANS: D
An ineffective cough impairs normal clearance mechanisms and increases the likelihood of re-tained secretions and gas absorption atelectasis in the patient with excessive mucus production. For this reason, patients with a history of lung disease that causes increased mucus production (e.g., chronic bronchitis) are most prone to develop complications in the postoperative period. Similarly, a significant history of cigarette smoking should alert the respiratory therapist to the high risk for respiratory complications with surgery.




MirandaLo

  • Member
  • Posts: 538
Reply 2 on: Jul 16, 2018
:D TYSM


Jsherida

  • Member
  • Posts: 314
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

Computer programs are available that crosscheck a new drug's possible trade name with all other trade names currently available. These programs detect dangerous similarities between names and alert the manufacturer of the drug.

Did you know?

Multiple experimental evidences have confirmed that at the molecular level, cancer is caused by lesions in cellular DNA.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

Did you know?

Fatal fungal infections may be able to resist newer antifungal drugs. Globally, fungal infections are often fatal due to the lack of access to multiple antifungals, which may be required to be utilized in combination. Single antifungals may not be enough to stop a fungal infection from causing the death of a patient.

Did you know?

Most fungi that pathogenically affect humans live in soil. If a person is not healthy, has an open wound, or is immunocompromised, a fungal infection can be very aggressive.

For a complete list of videos, visit our video library